参考文献/References:
[1] HUNTER D J,BIERMA-ZEINSTRA S.Osteoarthritis[J].Lancet,2019.DOI:10.1016/S0140-6736(19)30417-9.
[2] PRIMORAC D,MOLNAR V,ROD E,et al.Knee osteoarthritis:a review of pathogenesis and state-of-the-Art Non-Operative Therapeutic Considerations[J].Genes(Basel),2020,11(8):E854-E861.
[3] BEARD D J,DAVIES L J,COOK J A,et al.The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis(TOPKAT):5-year outcomes of a randomised controlled trial[J].Lancet,2019,394(10200):746-756.
[4] 沈淑劲,卢建华,樊炳楷,等.中医药预防全膝关节置换术后深静脉血栓形成的研究进展[J].中国中医骨伤科杂志,2018,26(10):86-88.
[5] FUJITA S,HIROTA S,ODA T,et al.Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan[J].Clin Orthop Relat Res,2000,37(5):168-174.
[6] KO P S,CHAN W F,SIU T H,et al.Deep venous thrombosis after total hip or knee arthroplasty in a “low-risk” Chinese population[J].J Arthroplasty,2003,18(2):174-179.
[7] TATSUMI K,MACKMAN N.Tissue factor and atherothrombosis[J].J Atheroscler Thromb,2015,22(6):543-549.
[8] CHAN L W,LUO X P,NI H C,et al.High levels of LDL-C combined with low levels of HDL-C further increase platelet activation in hypercholesterolemic patients[J].Braz J Med Biol Res,2015,48(2):167-173.
[9] 中华医学会骨科学分会关节外科学组.骨关节炎诊疗指南(2018年版)[J].中华骨科杂志,2018,38(12):705-715.
[10] 戴小宇,朱文骏,朱晓文,等.后交叉韧带重建术后下肢深静脉血栓的危险因素[J].中国矫形外科杂志,2019,27(14):1279-1283.
[11] 诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中华心血管病杂志,2016,31(10):833-853.
[12] PRANDONI P,BILORA F,MARCHIORI A,et al.An association between atherosclerosis and venous thrombosis[J].N Engl J Med,2003,348(15):1435-1441.
[13] DEGUCHI H,PECHENIUK N M,ELIAS D J,et al.High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men[J].Circulation,2005,112(6):893-899.
[14] DELLUC A,MALECOT J M,KERSPERN H,et al.Lipid parameters,lipid lowering drugs and the risk of venous thromboembolism[J].Atherosclerosis,2012,220(1):184-188.
[15] 张霞,杨扬,齐宝庆.血脂水平与下肢深静脉血栓形成的相关性分析[J].山东医药,2010,50(11):95-96.
[16] AGENO W,BECATTINI C,BRIGHTON T,et al.Cardiovascular risk factors and venous thromboembolism:a meta-analysis[J].Circulation,2008,117(1):93-102.
[17] LIMA JJ,MAURAS N,KISSOON N,et al.Influence of sex and beta2 adrenergic receptor haplotype on resting and terbutaline-stimulated whole body lipolysis[J].Metabolism,2005,54(4):492-499.
[18] MITTENDORFER B.Sexual dimorphism in human lipid metabolism[J].J Nutr,2005,135(4):681-686.
[19] KOSE R,SARGIN G,SENTURK T,et al.The association between clinically suspect arthralgia and adipokines in obese patients[J].Acta Reumatol Port,2018,43(4):284-290.
[20] JACKSON S P,DARBOUSSET R,SCHOENWAELDER S M.Thromboinflammation:challenges of therapeutically targeting coagulation and other host defense mechanisms[J].Blood,2019,133(9):906-918.
[21] BORGEL D,BIANCHINI E,LASNE D,et al.Inflammation in deep vein thrombosis:a therapeutic target?[J].Hematology,2019,24(1):742-750.
[22] KUNUTSOR S K,SEIDU S,KHUNTI K.Statins and primary prevention of venous thromboembolism:a systematic review and meta-analysis[J].Lancet Haematol,2017,4(2):e83-e93.
[23] SUN Y,CHEN D,XU Z,et al.Incidence of symptomatic and asymptomatic venous thromboembolism after elective knee arthroscopic surgery:a retrospective study with routinely applied venography[J].Arthroscopy,2014,30(7):818-822.